Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.14 USD | +1.04% | +2.53% | +14.61% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.61% | 1.66B | |
+8.84% | 114B | |
+11.48% | 104B | |
-12.84% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.38% | 17.89B | |
+8.01% | 14.28B | |
+34.44% | 12.55B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Oppenheimer Raises Soleno Therapeutics Price Target to $14 Form $8, Maintains Outperform Rating